PANP25: Tackling Hidradenitis Suppurativa: Exploring Current and Emerging Therapies
Released on
May 31, 2025
PANP25: Tackling Hidradenitis Suppurative: Exploring Current and Emerging Therapies
This activity is supported by educational grants from Incyte and Novartis Pharmaceuticals Corporation.